GERM ETFMG Treatments, Testing and Advancements ETF
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
No price history on file.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| GERM | +3.0% | -3.3% | -1.3% | +1.1% | — | — |
| Equity average (4726 funds) | -2.4% | -5.0% | +4002.3% | +2568.4% | +14.2% | +3.7% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$24K net.
Holdings · as of Aug 11, 2024
| # | Holding | Weight |
|---|---|---|
| 1 | ALNY Alnylam Pharmaceuticals Inc | 11.39% |
| 2 | LH Labcorp Holdings Inc | 7.20% |
| 3 | DGX Quest Diagnostics Inc | 6.61% |
| 4 | BNTX BioNTech SE | 5.01% |
| 5 | BIO Bio-Rad Laboratories Inc | 4.74% |
| 6 | PCVX Vaxcyte Inc | 4.52% |
| 7 | QDEL QuidelOrtho Corp | 4.11% |
| 8 | BCRX BioCryst Pharmaceuticals Inc | 3.70% |
| 9 | IMCR Immunocore Holdings PLC | 3.67% |
| 10 | ZLAB Zai Lab Ltd | 3.60% |
| 11 | MRNA Moderna Inc | 3.46% |
| 12 | DVAX Dynavax Technologies Corp | 3.42% |
| 13 | IBRX ImmunityBio Inc | 3.14% |
| 14 | VIR Vir Biotechnology Inc | 2.79% |
| 15 | NVAX Novavax Inc | 2.50% |
| 16 | OPK OPKO Health Inc | 2.46% |
| 17 | CVAC CureVac NV | 1.73% |
| 18 | FLGT Fulgent Genetics Inc | 1.68% |
| 19 | ABUS Arbutus Biopharma Corp | 1.62% |
| 20 | ADPT Adaptive Biotechnologies Corp | 1.55% |
| 21 | SIGA SIGA Technologies Inc | 1.45% |
| 22 | ARCT Arcturus Therapeutics Holdings Inc | 1.14% |
| 23 | GILD Gilead Sciences Inc | 1.01% |
| 24 | REGN Regeneron Pharmaceuticals Inc | 0.99% |
| 25 | ABBV AbbVie Inc | 0.98% |
| 26 | JNJ Johnson & Johnson | 0.96% |
| 27 | LLY Eli Lilly & Co | 0.93% |
| 28 | SNY Sanofi SA | 0.92% |
| 29 | ABT Abbott Laboratories | 0.91% |
| 30 | TAK Takeda Pharmaceutical Co Ltd | 0.89% |
| 31 | AZN AstraZeneca PLC | 0.88% |
| 32 | EBS Emergent BioSolutions Inc | 0.87% |
| 33 | PFE Pfizer Inc | 0.86% |
| 34 | GSK GSK PLC | 0.84% |
| 35 | MRK Merck & Co Inc | 0.76% |
| 36 | OCGN Ocugen Inc | 0.76% |
| 37 | OSUR OraSure Technologies Inc | 0.73% |
| 38 | AVIR Atea Pharmaceuticals Inc | 0.66% |
| 39 | ENTA Enanta Pharmaceuticals Inc | 0.62% |
| 40 | INO Inovio Pharmaceuticals Inc | 0.52% |
| 41 | CRMD CorMedix Inc | 0.49% |
| 42 | XBIT XBiotech Inc | 0.48% |
| 43 | CASH&OTHER Cash & Other | 0.35% |
| 44 | AGPXX Invesco Government & Agency Portfolio 12/31/2031 | 0.35% |
| 45 | IVVD Invivyd Inc | 0.29% |
| 46 | VXRT Vaxart Inc | 0.24% |
| 47 | RENB Renovaro Inc | 0.22% |
| 48 | IFRX InflaRx NV | 0.19% |
| 49 | HLVX HilleVax Inc | 0.19% |
| 50 | CMRX Chimerix Inc | 0.18% |
| 51 | CVM CEL-SCI Corp | 0.16% |
| 52 | GRTS Gritstone bio Inc | 0.13% |
| 53 | CUE Cue Biopharma Inc | 0.07% |
| 54 | ANTX AN2 Therapeutics Inc | 0.07% |
| 55 | SCLX Scilex Holding Co | 0.00% |
| 56 | 2298465D Gurnet Point Capital LLC | 0.00% |
| 57 | 2334482D AstraZeneca PLC | 0.00% |
Sector breakdown
Not on file.
Country breakdown
Not on file.
Distributions
No distributions on file.
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in GERM in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 16, 2026. This is historical data, not investment advice. Report a data error
